Ardent Health Partners Overview
Latest ROE for Ardent Health Partners: 5.79% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ Follow5.79%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Ardent Health Partners (ARDT) currently reports a ROE of 5.79%. That is above the sector sector average of -5.68%. Use the charts on this page to explore Ardent Health Partners's ROE history and peer comparisons.
Ardent Health Partners's ROE of 5.79% is higher than the its sector sector average of -5.68%. That is roughly 201.9% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Ardent Health Partners's current 5.79% should be judged against industry norms (sector average: -5.68%) and against ARDT's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 5.79%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -5.68%. From there, open related valuation or income-statement pages for Ardent Health Partners, and consider following ARDT for alerts when major investors trade the stock.
